Puneet S. Arora - Sep 3, 2024 Form 3 Insider Report for Skye Bioscience, Inc. (SKYE)

Role
Chief Medical Officer
Signature
/s/ Kaitlyn Arsenault, as Attorney-in-Fact
Stock symbol
SKYE
Transactions as of
Sep 3, 2024
Transactions value $
$0
Form type
3
Date filed
9/4/2024, 05:25 PM

No securities are beneficially owned.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney